'Suicidal ideation' leads to end of Amgen-AstraZeneca drug partnership
May 26, 2015 at 10:36 AM EDT
Amgen has pulled out of a co-development deal it had with AstraZeneca for an experimental psoriasis drug, which was in the late stages of clinical development, after observing “suicidal ideation” in some patients during clinical testing of the new drug candidate...